Clinical Cancer Research, Vol 3, Issue 1 51-55, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed

T Stewart, R Henderson, H Grayson and G Opelz
Ottawa General Hospital, Ottawa, Ontario, K1H 8L6 Canada. Tstewottkcan@msm.com

The incidence of gastric, colonic, and rectal cancers was determined in a cohort of 73,076 men and women chronically immunosuppressed after heart or renal transplantation, to test the hypothesis that there would be a reduced incidence of gastric cancer by dampening chronic gastritis secondary to infection caused by Helicobacter pylori. Follow-up was from 1-13 years. No change in the incidence of gastric cancer was found (32 cases observed, 32.86 expected). An increase in colon cancer was found (75 cases observed, 62.27 expected). A significant reduction in the incidence of rectal cancer was found (15 cases observed, 41.5 expected). This led to a chi2 of 16.92 with 1 degree of freedom, significant at the 0.1% level. The effect was greater in men than women and more marked in heart recipients than in those receiving renal transplants. This unexpected finding led to a review of experiments in mice and rats that present evidence for immune promotion of large-bowel cancers induced by carcinogens by gut-associated lymphoid tissue. We conclude that an analysis of immune function in gut-associated lymphoid tissue in the stomach, colon, and rectum in healthy and immunosuppressed patients may lead to a better understanding of immunosurveillance in the colon and immune promotion of rectal cancers.

This article has been cited by other articles:

				E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529. [Abstract] [Full Text] [PDF]

				J. H. Helderman and S. Goral Gastrointestinal Complications of Transplant Immunosuppression J. Am. Soc. Nephrol., January 1, 2002; 13(1): 277 - 287. [Full Text] [PDF]

				B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER Recommendations for the Outpatient Surveillance of Renal Transplant Recipients J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86. [Abstract] [Full Text] [PDF]

				F. Pierre, P. Perrin, E. Bassonga, F. Bornet, K. Meflah, and J. Menanteau T cell status influences colon tumor occurrence in Min mice fed short chain fructo-oligosaccharides as a diet supplement Carcinogenesis, October 1, 1999; 20(10): 1953 - 1956. [Abstract] [Full Text] [PDF]